International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma

This statement concludes that treating multiple myeloma (MM) patients with allogeneic stem-cell transplantation (Allo-SCT) is not more successful than autologous stem-cell transplantation. In addition, more guidelines are needed to be set in order to make Allo-SCT a better form of treatment.

Authors:

Lokhorst H, Einsele H, Vesole D, Bruno B, San Miguel J, Perez-Simon JA, Kroger N, Moreau P, Gahrton G, Gasparetto C, Giralt S, Bensinger W; International Myeloma Working Group.

Click here to view article:

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.